Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
暂无分享,去创建一个
David I Stuart | Raymond J Owens | Tomas Malinauskas | Helen M Ginn | Yuguang Zhao | Neil G Paterson | R. Owens | D. Stuart | G. Screaton | J. Radecke | M. Carroll | P. Rijal | A. Townsend | N. Paterson | Yuguang Zhao | H. Ginn | E. Fry | Jingshan Ren | J. Mongkolsapaya | Helen M. E. Duyvesteyn | J. Huo | L. Carrique | T. Malinauskas | R. Ruza | P. Shah | T. Tan | N. Coombes | K. Bewley | P. Supasa | Elizabeth E Fry | Jingshan Ren | Juthathip Mongkolsapaya | Miles Carroll | Gavin R Screaton | Jiandong Huo | Alain Townsend | Daming Zhou | Helen ME Duyvesteyn | Loic Carrique | Reinis R Ruza | Pranav NM Shah | Tiong Kit Tan | Pramila Rijal | Naomi Coombes | Kevin Bewley | Julika Radecke | Piyasa Supasa | D. Zhou | Julika Radecke
[1] Gwyndaf Evans,et al. DIALS: implementation and evaluation of a new integration package , 2018, Acta crystallographica. Section D, Structural biology.
[2] Graeme Winter,et al. xia2: an expert system for macromolecular crystallography data reduction , 2010 .
[3] Kai Zhang,et al. Gctf: Real-time CTF determination and correction , 2015, bioRxiv.
[4] Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, Emerging microbes & infections.
[5] Antibody therapies for the prevention and treatment of viral infections , 2017, npj Vaccines.
[6] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[7] Frank Grosveld,et al. A human monoclonal antibody blocking SARS-CoV-2 infection , 2020, Nature Communications.
[8] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[9] Jaap Goudsmit,et al. Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants , 2006, PLoS medicine.
[10] Torsten Seemann,et al. Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia , 2020, The Medical journal of Australia.
[11] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[12] Linqi Zhang,et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.
[13] I. Wilson,et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV , 2020, Science.
[14] William C. Hwang,et al. Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R* , 2006, Journal of Biological Chemistry.
[15] Lester G. Carter,et al. A procedure for setting up high‐throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization , 2005, Acta crystallographica. Section D, Biological crystallography.
[16] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[17] G. Kärber,et al. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche , 1931, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[18] Xiaolong Qi,et al. Real estimates of mortality following COVID-19 infection , 2020, The Lancet Infectious Diseases.
[19] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[20] Wenhui Li,et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] Dariusz M Plewczynski,et al. Three-dimensional Epigenome Statistical Model: Genome-wide Chromatin Looping Prediction , 2018, Scientific Reports.
[22] S. Harrison,et al. Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.
[23] Daniel Wrapp,et al. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis , 2018, Scientific Reports.
[24] Hsin-Jung Li,et al. Development of therapeutic antibodies for the treatment of diseases , 2020, Journal of Biomedical Science.
[25] R. Couch,et al. Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus , 2012, PloS one.
[26] Christopher J. Williams,et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.
[27] S. Perlman,et al. Immunopathogenesis of coronavirus infections: implications for SARS , 2005, Nature Reviews Immunology.
[28] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[29] David J. Fleet,et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.
[30] Susmita Roy,et al. Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike , 2020, The journal of physical chemistry letters.
[31] D. Dimitrov,et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies , 2007, Proceedings of the National Academy of Sciences.
[32] R. Owens,et al. A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells. , 2008, Protein expression and purification.
[33] D I Stuart,et al. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. , 1979, Journal of molecular biology.
[34] David I. Stuart,et al. A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation , 2003 .
[35] N. Grist. Diagnostic Methods in Clinical Virology , 1966 .
[36] J. W. Schrader,et al. Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem , 2012, Front. Immun..
[37] R. Owens,et al. The production of glycoproteins by transient expression in Mammalian cells. , 2009, Methods in molecular biology.
[38] Alexey Teplyakov,et al. Antibody modeling assessment II. Structures and models , 2014, Proteins.
[39] Yuelong Shu,et al. GISAID: Global initiative on sharing all influenza data – from vision to reality , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[40] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[41] N. Pannu,et al. REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.
[42] Barney S. Graham,et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.
[43] D. Hamer. Faculty Opinions recommendation of Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[44] Susmita Roy,et al. Dynamical asymmetry exposes 2019-nCoV prefusion spike , 2020, bioRxiv.
[45] G. Gilliland,et al. Structural diversity in a human antibody germline library , 2016, mAbs.
[46] Lisa E. Gralinski,et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence , 2015, Nature Medicine.
[47] Fang Li,et al. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry , 2019, Journal of Virology.
[48] R. Owens,et al. Transient expression in HEK 293 cells: an alternative to E. coli for the production of secreted and intracellular mammalian proteins. , 2015, Methods in molecular biology.
[49] A. Walls,et al. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.
[50] Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[51] Xinquan Wang,et al. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 , 2018, PLoS pathogens.